One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Direct-to-consumer microbiome testing needs regulation
doi : 10.1016/S2468-1253(24)00163-8
Volume 9, Issue 7, July 2024, Page 583
Negative screening colonoscopy and long-term colorectal cancer risk—is it time to extend the screening interval?
J E G IJspeert a, M E van Leerdam a b
doi : 10.1016/S2468-1253(24)00115-8
Volume 9, Issue 7, July 2024, Pages 584-585
Rethinking colorectal cancer prognosis: beyond microsatellite status
Elisabetta Fenocchio a
doi : 10.1016/S2468-1253(24)00129-8
Volume 9, Issue 7, July 2024, Pages 585-586
Providing trauma-informed care for all in gastroenterology
Christina H Jagielski a, Alexandra Fuss b c, Tiffany H Taft d
doi : 10.1016/S2468-1253(24)00154-7
Volume 9, Issue 7, July 2024, Pages 587-588
The HEPSANET score to assess treatment eligibility of chronic hepatitis B in Africa
Jian Wang a b, Shaoqiu Zhang a, Chao Jiang c, Chao Wu a b, Rui Huang a b c
doi : 10.1016/S2468-1253(24)00114-6
Volume 9, Issue 7, July 2024, Page 589
The HEPSANET score to assess treatment eligibility of chronic hepatitis B in Africa – Authors' reply
Nicolas Minier a, Asgeir Johannessen b c, Roger Sombié d, Maud Lemoine e f, Yusuke Shimakawa a
doi : 10.1016/S2468-1253(24)00123-7
Volume 9, Issue 7, July 2024, Pages 589-590
Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial
Arno R Bourgonje a b, Marijn C Visschedijk a, Eleonora A M Festen a, Rinse K Weersma a, Gerard Dijkstra a
doi : 10.1016/S2468-1253(24)00120-1
Volume 9, Issue 7, July 2024, Pages 590-591
Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial
Vinay Borkar a, Yatin Lunagariya a, Shivani Chopra a, Deepak Sasikumar a, Meghraj Ingle a
doi : 10.1016/S2468-1253(24)00112-2
Volume 9, Issue 7, July 2024, Page 591
Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial
Jack Satsangi a, Jan Nowak b, Rahul Kalla c, Jean-Frederic Colombel d
doi : 10.1016/S2468-1253(24)00082-7
Volume 9, Issue 7, July 2024, Pages 591-592
Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial
Rirong Chen a, Shenghong Zhang a b
doi : 10.1016/S2468-1253(24)00077-3
Volume 9, Issue 7, July 2024, Page 592
Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial – Authors' reply
Nurulamin M Noor a c, James C Lee d e, Simon Bond b, Miles Parkes a c
doi : 10.1016/S2468-1253(24)00150-X
Volume 9, Issue 7, July 2024, Pages 592-594
Resmetirom for MASH-related cirrhosis
Gong Feng a b, Virginia Hernandez-Gea c, Ming-Hua Zheng d e
doi : 10.1016/S2468-1253(24)00124-9
Volume 9, Issue 7, July 2024, Page 594
The role of ERAS in robotic pancreaticoduodenectomy
Dimitrios Moris a, Sabino Zani a
doi : 10.1016/S2468-1253(24)00090-6
Volume 9, Issue 7, July 2024, Pages 594-595
The role of ERAS in robotic pancreaticoduodenectomy – Authors' reply
Qu Liu a b, Rong Liu a
doi : 10.1016/S2468-1253(24)00160-2
Volume 9, Issue 7, July 2024, Pages 595-596
Correction to Lancet Gastroenterol Hepatol 2024; 9: 34–44
doi : 10.1016/S2468-1253(24)00168-7
Volume 9, Issue 7, July 2024, Page e10
Correction to Lancet Gastroenterol Hepatol 2024; 9: 620–31
doi : 10.1016/S2468-1253(24)00169-9
Volume 9, Issue 7, July 2024, Page e10
Research in Brief
Holly Baker
doi : 10.1016/S2468-1253(24)00164-X
Volume 9, Issue 7, July 2024, Page 597
The Mediterranean diet for gastrointestinal conditions—premature or panacea?
Heidi M Staudacher, Elena S George
doi : 10.1016/S2468-1253(24)00165-1
Volume 9, Issue 7, July 2024, Page 598
Blood Matters
Fiyinfolu Deborah Oyekan
doi : 10.1016/S2468-1253(24)00167-5
Volume 9, Issue 7, July 2024, Page 600
Duration of risk reduction in colorectal cancer incidence and mortality after a complete colonoscopy in Ontario, Canada: a population-based cohort study
Arlinda Ruco PhD a b c d, Prof Rahim Moineddin PhD e, Prof Rinku Sutradhar PhD g h, Jill Tinmouth MD PhD g i j, Qing Li MMath h, Prof Linda Rabeneck MD MPH e g h, M Elisabetta Del Giudice MD MSc e k, Catherine Dubé MD MSc l, Prof Nancy N Baxter MD PhD f g h m n
doi : 10.1016/S2468-1253(24)00084-0
Volume 9, Issue 7, July 2024, Pages 601-608
Clinical significance of combined tumour-infiltrating lymphocytes and microsatellite instability status in colorectal cancer: a systematic review and network meta-analysis
Durgesh Wankhede MS a e, Tanwei Yuan MSc a, Prof Matthias Kloor MD b f, Prof Niels Halama MD c g h, Prof Hermann Brenner MD a d, Prof Michael Hoffmeister PhD a
doi : 10.1016/S2468-1253(24)00091-8
Volume 9, Issue 7, July 2024, Pages 609-619
Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Alexander G Miethke MD a, Prof Adib Moukarzel MD b, Prof Gilda Porta MD c, Joshue Covarrubias Esquer MD d, Piotr Czubkowski PhD e, Prof Felipe Ordonez MD f, Antonella Mosca MD g, Amal A Aqul MD h, Prof Robert H Squires MD i, Prof Etienne Sokal MD j, Daniel D'Agostino MD k, Prof Ulrich Baumann MD l, Lorenzo D'Antiga MD m n, Nagraj Kasi MD o, Nolwenn Laborde MD p, Prof Cigdem Arikan MD q, Chuan-Hao Lin MD r, Prof Susan Gilmour MD s, Prof Naveen Mittal MD t, Fang Kuan Chiou MD u…Prof Richard J Thompson MD ae
doi : 10.1016/S2468-1253(24)00080-3
Volume 9, Issue 7, July 2024, Pages 620-631
Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial
Nadia Ovchinsky MD a, Madeleine Aumar PhD b, Prof Alastair Baker MB ChB c, Prof Ulrich Baumann MD d, Prof Philip Bufler Dr med e, Mara Cananzi MD PhD f, Piotr Czubkowski MD g, Prof Özlem Durmaz MD h, Prof Ryan Fischer MD i, Giuseppe Indolfi MD PhD j, Wikrom W Karnsakul MD k, Florence Lacaille MD l, Prof Way S Lee MD m, Prof Giuseppe Maggiore MD n, Prof Philip Rosenthal MD o, Mathias Ruiz MD p, Prof Etienne Sokal MD PhD q, Ekkehard Sturm MD r, Wendy van der Woerd MD PhD s, Prof Henkjan J Verkade MD PhD t…Jan P Mattsson PhD v
doi : 10.1016/S2468-1253(24)00074-8
Volume 9, Issue 7, July 2024, Pages 632-645
Pathophysiology and therapeutic options for cirrhotic portal hypertension
Sergi Guixé-Muntet PhD a †, Sergio Quesada-Vázquez PhD a †, Prof Jordi Gracia-Sancho PhD FAASLD a b
doi : 10.1016/S2468-1253(23)00438-7
Volume 9, Issue 7, July 2024, Pages 646-663
Targeting the EGFR signalling pathway in metastatic colorectal cancer
Stefania Napolitano MD PhD a, Giulia Martini MD PhD a, Davide Ciardiello MD PhD a b, Sara Del Tufo MD a, Erika Martinelli MD PhD a, Teresa Troiani MD PhD a, Prof Fortunato Ciardiello MD PhD a
doi : 10.1016/S2468-1253(23)00479-X
Volume 9, Issue 7, July 2024, Pages 664-676
